Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation, randomised, singleblind, placebo-controlled phase Ib/IIa clinical trial

  1. Álvaro-Gracia, J.M.
  2. Jover, J.A.
  3. García-Vicuña, R.
  4. Carreño, L.
  5. Alonso, A.
  6. Marsal, S.
  7. Blanco, F.
  8. Martínez-Taboada, V.M.
  9. Taylor, P.
  10. Martín-Martín, C.
  11. DelaRosa, O.
  12. Tagarro, I.
  13. Díaz-González, F.
Journal:
Annals of the Rheumatic Diseases

ISSN: 1468-2060 0003-4967

Year of publication: 2017

Volume: 76

Issue: 1

Pages: 196-202

Type: Article

DOI: 10.1136/ANNRHEUMDIS-2015-208918 GOOGLE SCHOLAR

Sustainable development goals